Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis resul... by Grande, Enrique, MD, Arranz, José Á, MD, De Santis, Maria, MD, Bamias, Aristotelis, Prof, Kikuchi, Eiji, Prof, del Muro, Xavier Garcia, MD, Park, Se Hoon, Prof, De Giorgi, Ugo, MD, Alekseev, Boris, Prof, Mencinger, Marina, MD, Izumi, Kouji, MD, Schutz, Fabio A, MD, Puente, Javier, MD, Li, Jian-Ri, MD, O'Donnell, Peter H, MD, Kalebasty, Arash Rezazadeh, MD, Ye, Dingwei, Prof, Mariathasan, Sanjeev, PhD, Bene-Tchaleu, FabioIa, MSc, Bernhard, Sandrine, PharmD, Lee, Chooi, MD, Davis, Ian D, Prof, Galsky, Matthew D, Prof

Get full text

Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, contr... by Bamias, Aristotelis, Prof, Davis, Ian D, Prof, Galsky, Matthew D, Prof, Arranz, José Á, MD, Kikuchi, Eiji, Prof, Grande, Enrique, MD, del Muro, Xavier Garcia, MD, Park, Se Hoon, Prof, De Giorgi, Ugo, MD, Alekseev, Boris, MD, Mencinger, Marina, MD, Izumi, Kouji, MD, Schutz, Fabio A, MD, Puente, Javier, MD, Li, Jian-Ri, MD, Panni, Stefano, MD, Gumus, Mahmut, Prof, Özgüroğlu, Mustafa, Prof, Mariathasan, Sanjeev, PhD, Poloz, Yekaterina, PhD, Bene-Tchaleu, Fabiola, MSc, Lee, Chooi, MD, Bernhard, Sandrine, PharmD, De Santis, Maria, MD

Get full text